4.4 Article

Natural Compound α-PGG and Its Synthetic Derivative 6Cl-TGQ Alter Insulin Secretion: Evidence for Diminishing Glucose Uptake as a Mechanism

Journal

Publisher

DOVE MEDICAL PRESS LTD
DOI: 10.2147/DMSO.S284295

Keywords

glucose-stimulated insulin secretion; calcium influx; glucose transporter; alpha-PGG; 6Cl-TGQ

Funding

  1. Ohio University
  2. NIH [R15 DK121247]

Ask authors/readers for more resources

The natural compound alpha-PGG and its synthetic derivative 6Cl-TGQ were found to suppress glucose uptake in beta-cells, leading to decreased glycolysis and ATP synthesis, ultimately resulting in reduced insulin secretion. While these compounds exhibit insulin-like effects in peripheral tissues, they do not act through the insulin receptor in islets.
Purpose: Previously we showed that natural compound alpha-penta-galloyl-glucose (alpha-PGG) and its synthetic derivative 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-alpha-D-glucopyranose (6Cl-TGQ) act to improve insulin signaling in adipocytes by increasing glucose transport. In this study, we investigated the mechanism of actions of alpha-PGG and 6Cl-TGQ on insulin secretion. Methods: Mouse islets and/or INS-1832/13 beta-cells were used to test the effects of our compounds on glucose-stimulated insulin secretion (GSIS), intracellular calcium [Ca2+], using fura-2AM, glucose transport activity via a radioactive glucose uptake assay, intracellular ATP/ADP, and extracellular acidification (ECAR) and mitochondrial oxygen consumption rates (OCAR) using Seahorse metabolic analysis. Results: Both compounds reduced GSIS in beta-cells without negatively affecting cell viability. The compounds primarily diminished glucose uptake into islets and beta-cells. Despite insulin-like effects in the peripheral tissues, these compounds do not act through the insulin receptor in islets. Further interrogation of the stimulus-secretion pathway showed that all the key metabolic factors involved in GSIS including ECAR, OCAR, ATP/ADP ratios, and [Ca2+](i) of INS-1832/13 cells were diminished after the compound treatment. Conclusion: The compounds suppress glucose uptake of the beta-cells, which consequently slows down the rates of glycolysis and ATP synthesis, leading to decrease in [Ca2+], and GSIS. The difference between adipocytes and beta-cells in effects on glucose uptake is of great interest. Further structural and functional modifications could produce new compounds with optimized therapeutic potentials for different target cells. The higher potency of synthetic 6Cl-TGQ in enhancing insulin signaling in adipocytes but lower potency in reducing glucose uptake in beta-cells compared to alpha-PGG suggests the feasibility of such an approach.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available